Abstract
A complement-independent eosinophil chemotactic factor (ECF) is described which is released from peripheral leukocytes of allergic and normal human volunteers after antigen stimulation and after exposure to anti-IgE. Dose response and time-release curves for ECF and histamine run closely parallel in this system. Histamine by itself is shown to have no effect on chemotaxis at the concentrations present in antigen-induced release, but is inhibitory at very high concentrations. Evidence suggests that the ECF released from human leukocytes is derived from basophils and is similar, or identical, to the ECF released from mast cells.
Similar content being viewed by others
References
Litt, M. 1967. Studies in experimental eosinophilia. VII. Eosinophils in lymph nodes during the first 24 hr following primary antigenic stimulation.J. Immunol 93:807–813.
Sabesin, S.M. 1963. A function of the eosinophil: Phagocytosis of antigen-antibody complexes.Proc. Soc. Exp. Biol. Med. 112:667–670.
Ishikawa, T., K. Wicker, andC.E. Arbesman. 1972, Selective uptake of soluble antigen antibody complexes, prepared in different proportions, by human eosinophils.Fed. Proc. 31:744.
Mickenberg, I.D., R.K. Root, andS.M. Wolff. 1972. Bactericidal and metabolic properties of human eosinophils.Blood 39:67–80.
Miller, F., E. DeHarven, andG.E. Palade. 1966. The structure of eosinophil leukocyte granules in rodents and in man.J. Cell Biol. 31:349–362.
Gleich, G.J., D.A. Loegering, andJ.E. Maldonada. 1973. Identification of a major basic protein in guinea pig eosinophil granules.J. Exp. Med. 137:1459–1471.
Gessner, T.P., S.R. Himmelhoch, andE. Shelton. 1973. Partial characterization of the protein components of eosinophil granules isolated from guinea pig exudates.Arch. Biochem. Biophys. 156:383–389.
Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.J. Exp. Med. 115:453–466.
Kay, A.B. 1970. Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin.Clin. Exp. Immunol. 6:75–86.
Kay, A.B. 1970. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.Clin. Exp. Immunol. 7:723–737.
Cohen, S.G., andT.M. Sapp. 1963. Experimental eosinophilia. IV. Eosinotactic influences of polysaccharides.Exp. Mol. Pathol. 2:74–82.
Colley, D.G. 1973. Eosinophils and immune mechanisms. I. Eosinophil stimulation promoter (ESP): A lymphokine induced by specific antigen or phytohemagglutinin.J. Immunol. 110:1419–1423.
Greene, B.M., andD.G. Colley. 1974. Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation prompter.J. Immunol. 113:910–917.
Cohen, S., andP.A. Ward 1971.In vitro andin vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.J. Exp. Med. 133: 133–146.
Ward, P.A., C.G. Cochrane, andH.J. Müller-Eberhard. 1965. The role of serum complement in chemotaxis of leukocytesin vitro.J. Exp. Med. 122:327–331.
Ward, P.S., C.G. Cochrane, andH.J. Müller-Eberhard. 1966. Further studies on the chemotactic factor of complement and its formationin vivo.Immunology 11:141–153.
Ward, P.A. 1969. Chemotaxis of human eosinophils.Am. J. Pathol. 53:121–128.
Kay, A.B., D.J. Stechschulte, andK.F. Austen. 1971. An eosinophil leukocyte chemotactic factor of anaphylaxis.J. Exp. Med. 133:602–619.
Kay, A.B., andK.F. Austen. 1971. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.J. Immunol. 107:899–902.
Kaliner, M., S.I. Wasserman, andK.F. Austen. 1973. Immunologic release of chemical mediators from human nasal polyps.N. Engl. J. Med. 289:277–281.
Wasserman, S.I., E.J. Goetzl, L. Ellman, andK.F. Austen. 1974. Tumor-associated eosinophilotactic factor.N. Engl. J. Med. 290:420–424.
Wasserman, S.I., E.J. Goetzl, andK.F. Austen. 1974. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A).J. Immunol. 112:351–358.
Lewis, R.A., E.J. Goetzl, S.I. Wasserman, F.H. Valone, R.H. Rubin, andK.F. Austen. 1975. The release of four mediators of immediate hypersensitivity from human leukemic basophils.J. Immunol. 114:87–92.
Wasserman, S.J., E.J. Goetzl, M. Kaliner, andK.F. Austen. 1974. Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung.Immunology 26:677–684.
Lichtenstein, L.M., andR. DeBernardo. 1971. The immediate allergic response:In vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.J. Immunol. 107:1131–1136.
Parish, W.E. 1972. Eosinophilia. III. The anaphylactic release from isolated human basophils of a substance that selectively attracts eosinophils.Clin. Allergy 2:381–390.
Lichtenstein, L.M., andA.G. Osler. 1964. Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen.J. Exp. Med. 120:507–530.
Böyum, A. 1968. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1 g gravity field.Scand. J. Clin. Lab. Invest. 21 Suppl. 97:51–76.
Day, R.P. 1970. Eosinophil cell separation from human peripheral blood.Immunology 18:955–959.
Litt, M. 1960. Studies in experimental eosinophilia. I. Repeated quantitation of peritoneal eosinophilia in guinea pigs by a method of peritoneal lavage.Blood 16: 1318–1329.
Clark, R.A., J.I. Gallin, andA. P. Kaplan. 1975. Identification of histamine as a chemotactic factor for human eosinophils.Clin. Res. 23:288A.
Fowler, J.W., andF.C. Lowell. 1966. The accumulation of eosinophils as an allergic response to allergen applied to the denuded skin surface.J. Allergy 37:19–28.
Ishizaka, T., R. DeBernardo, H. Tomioka, andL.M. Lichenstein. 1972. Identification of basophil granulocytes as a site of allergic histamine release.J. Immunol. 108:1000–1008.
Ishizaka, K., H. Tomioka, andT. Ishizaka. 1970. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes.J. Immunol. 105:1459–1467.
Sullivan, A.L., P.M. Grimley, andH. Metzger. 1971. Electron microscopic localization of immunoglobulin E on the surface membrane of human basophils.J. Exp. Med. 134:1403–1416.
Archer, R.K. 1959. Eosinophil leucocytes and their reactions to histamine and 5-hydroxytryptamine.J. Pathol. Bacterial. 78:95–103.
Rivkin, I., andE.L. Becker. 1972. Possible implication of cyclic 3′5′-adenosine monophosphate in the chemotaxis of rabbit peritoneal polymorphonuclear leukocytes.Fed. Proc. 31:657.
Hill, H.R., andP.G. Quie. 1974. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections.Lancet 1:183–187.
Clark, R.A., andA.P. Kaplan. 1975. Mediator release from human basophils.J. Allergy Clin. Immunol. 55:85.
Goetzl, E.J., andK.F. Austen. 1972. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.J. Exp. Med. 136:1564–1580.
Author information
Authors and Affiliations
Additional information
This work was supported by Grants 07290 and 08270 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Publication No. 197, O'Neill Research Laboratories.
Dr. Czarnetzki is recipient of the Stetler Research Fund for Women Physicians.
Rights and permissions
About this article
Cite this article
Czarnetzki, B.M., König, W. & Lichtenstein, L.M. Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes. Inflammation 1, 201–215 (1976). https://doi.org/10.1007/BF00917530
Issue Date:
DOI: https://doi.org/10.1007/BF00917530